CSIMarket
 

Healthcare Sector

Major Pharmaceutical Preparations Industry Growth  


Growth Rates by Company within Major Pharmaceutical Preparations Industry




Revenue Growth Net Income Growth
Company Quarter Y / Y Sequential Y / Y Sequential
Aadi Bioscience Inc 3Q 2023 up 40.38 % down -3.92 % - -
Abbvie inc 4Q 2023 down-5.42 % up 2.69 % down -66.67 % down -53.73 %
Abcellera Biologics Inc 4Q 2023 down-57.4 % up 39.08 % - -
Abeona Therapeutics Inc 3Q 2023 up 723.61 % down -84.86 % - -
American Bio Medica Corporation 1Q 2023 down-53.28 % down -2.38 % - -
Abbott Laboratories 4Q 2023 up 1.49 % up 0.97 % up 54.31 % up 11 %
Arbutus Biopharma Corp 3Q 2023 down-21.74 % up 0.15 % - -
Abvc Biopharma Inc 3Q 2023 down-62.42 % up 160.01 % - -
Acadia Pharmaceuticals Inc 3Q 2023 up 61.96 % up 28.12 % - -
Acer Therapeutics Inc 3Q 2023 - - - -
Adicet Bio Inc 3Q 2023 - - - -
Aclaris Therapeutics Inc 4Q 2023 up 126.62 % up 89.29 % - -
Acrivon Therapeutics Inc 3Q 2023 - - - -
Acelrx Pharmaceuticals Inc 3Q 2023 down-76.92 % down -53.75 % - -
Acasti Pharma Inc 3Q 2023 - - - -
Accustem Sciences Inc 2Q 2023 - - - -
Acurx Pharmaceuticals inc 3Q 2023 - - - -
Adial Pharmaceuticals Inc 3Q 2023 - - - -
Aditxt Inc 3Q 2023 down-61.47 % down -43.67 % - -
Addex Therapeutics Ltd 4Q 2022 down-51.22 % - - -
Advaxis Inc 1Q 2022 down-81.82 % - - -
Aeon Biopharma inc 3Q 2023 - - - -
Aeterna Zentaris Inc 4Q 2022 up 7.22 % - - -
Kaya Holdings Inc 3Q 2023 down-65.88 % up 7.07 % - -
Affimed N v 4Q 2022 up 2.45 % - - -
Agex Therapeutics Inc 2Q 2023 down-25 % down -10 % - -
Agios Pharmaceuticals Inc 4Q 2023 up 64.8 % down -4 % - -
Aeglea Biotherapeutics Inc 3Q 2023 - - - -
Agile Therapeutics Inc 3Q 2023 up 106.03 % up 19.03 % - -
Ainos Inc 3Q 2023 down-98.61 % down -14.24 % - -
Akebia Therapeutics Inc 3Q 2023 down-14.13 % down -25.42 % - -
Akero Therapeutics Inc 3Q 2023 - - - -
Akari Therapeutics Plc 4Q 2022 - - - -
Akouos inc 3Q 2022 - - - -
Albireo Pharma inc 3Q 2022 up 168.34 % up 19.81 % - -
Aldeyra Therapeutics Inc 3Q 2023 - - - -
Alimera Sciences Inc 3Q 2023 up 66.25 % up 32.1 % - -
Alkermes Plc 3Q 2023 up 50.95 % down -38.3 % - down -79.85 %
Allakos Inc 3Q 2023 - - - -
Allarity Therapeutics Inc 3Q 2023 - - - -
Alnylam Pharmaceuticals Inc 4Q 2023 up 31.25 % down -41.41 % - -
Alpine Immune Sciences Inc 3Q 2023 up 20.03 % up 16.87 % - -
Aileron Therapeutics Inc 3Q 2023 - - - -
Altimmune inc 3Q 2023 up 18000 % up 5933.33 % - -
Alx Oncology Holdings Inc 3Q 2023 - - - -
Alzamend Neuro Inc 3Q 2023 - - - -
Amylyx Pharmaceuticals Inc 3Q 2023 up 29666.09 % up 4.56 % - down -5.35 %
Ampio Pharmaceuticals inc 3Q 2023 - - - -
Amphastar Pharmaceuticals Inc 3Q 2023 up 50.3 % up 23.91 % up 210.08 % up 88.42 %
Amarin Corp Plcuk 3Q 2023 up 5.09 % down -17.6 % - -
Amneal Pharmaceuticals Inc 3Q 2023 up 13.84 % up 3.42 % - down -15.67 %
Applied Molecular Transport Inc 3Q 2023 - - - -
Anaptysbio inc 3Q 2023 up 156.61 % down -4.1 % - -
Anebulo Pharmaceuticals Inc 4Q 2023 - - - -
Ani Pharmaceuticals Inc 4Q 2023 up 39.71 % down -0.13 % - down -88.38 %
Anixa Biosciences Inc 2Q 2023 - - - -
Annexon Inc 3Q 2023 - - - -
An2 Therapeutics Inc 3Q 2023 - - - -
Annovis Bio inc 3Q 2023 - - - -
Apexigen Inc 2Q 2023 - - - -
Apellis Pharmaceuticals Inc 3Q 2023 up 400.54 % up 16.25 % - -
Applied Therapeutics Inc 3Q 2023 - - - -
Aprea Therapeutics Inc 3Q 2023 - - - -
Aptinyx Inc 1Q 2023 - - - -
Aptevo Therapeutics Inc 3Q 2023 - - - -
Aquestive Therapeutics Inc 3Q 2023 up 13.43 % down -1.8 % - -
Aravive Inc 3Q 2023 down-44.39 % up 116.33 % - up 17.87 %
Arcturus Therapeutics Holdings Inc 3Q 2023 up 237.65 % up 329.13 % - -
Aridis Pharmaceuticals Inc 4Q 2022 up 22.9 % up 204.01 % - -
Ardelyx Inc 4Q 2023 up 937.1 % down -8.3 % - -
Arcutis Biotherapeutics Inc 4Q 2023 up 356.81 % down -64.51 % - -
Artelo Biosciences Inc 3Q 2023 - - - -
Arvinas Inc 4Q 2023 - - - -
Arrowhead Pharmaceuticals Inc 4Q 2023 down-94.32 % down -77.94 % - -
Aslan Pharmaceuticals Limited 4Q 2022 - - - -
Assembly Biosciences Inc 3Q 2023 - - - -
Ascendis Pharma A 4Q 2022 up 557.93 % up 557.93 % - -
Assertio Holdings inc 3Q 2023 up 4.14 % down -13.09 % - -
Atai Life Sciences N v 3Q 2023 up 262.5 % down -49.42 % - -
Alterity Therapeutics Limited 2Q 2023 - - - -
Athersys Inc 3Q 2023 - - - -
180 Life Sciences Corp 3Q 2023 - - - -
Actinium Pharmaceuticals Inc 3Q 2023 - - - -
Athenex Inc 4Q 2022 down-67.71 % down -75.99 % - -
Atossa Therapeutics Inc 3Q 2023 - - - -
Adhera Therapeutics Inc 2Q 2023 - - up 173.74 % -
Avenue Therapeutics Inc 3Q 2023 - - - -
Astria Therapeutics inc 3Q 2023 - - - -
Aurinia Pharmaceuticals Inc 4Q 2023 up 58.59 % down -17.28 % - -
Avadel Pharmaceuticals Plc 3Q 2023 - up 368.85 % - -
Aveo Pharmaceuticals Inc 3Q 2022 up 100.68 % up 20.33 % - -
Atea Pharmaceuticals Inc 3Q 2023 - - - -
Avenir Wellness Solutions Inc 3Q 2023 - up 5.56 % - -
Aerovate Therapeutics Inc 2Q 2022 - - - -
Avalo Therapeutics Inc 3Q 2023 down-98.42 % down -63.3 % - -
Axim Biotechnologies Inc 3Q 2023 up 629.15 % down -3.5 % - -
Axsome Therapeutics Inc 3Q 2023 up 243.08 % up 23.76 % - -
Aytu Biopharma Inc 4Q 2023 down-15.51 % up 1.92 % - -
Astrazeneca Plc 4Q 2023 up 3.29 % up 3.29 % up 81.02 % up 81.02 %
Azitra Inc 2Q 2023 - - - -
Bridgebio Pharma Inc 3Q 2023 up 1110.36 % up 149.3 % - -
Atreca inc 3Q 2023 - - - -
Briacell Therapeutics Corp 2Q 2022 - - - -
Bicycle Therapeutics Plc 4Q 2023 up 67.38 % down -0.39 % - -
Bioadaptives Inc 3Q 2023 up 368.95 % up 569.05 % - -
Biodexa Pharmaceuticals Plc 4Q 2022 up 20.93 % up 20.93 % - -
Bullfrog Ai Holdings Inc 4Q 2022 - - - -
Biofrontera Inc 2Q 2023 down-40.5 % down -68.35 % - -
Beigene ltd 4Q 2023 up 66.67 % down -18.92 % - -
Bausch Health Companies Inc 4Q 2023 up 9.8 % up 7.6 % - -
Biohaven Ltd 3Q 2023 - - - -
Biora Therapeutics Inc 3Q 2023 - - - -
Biovie Inc 4Q 2023 - - - -
Bioxytran Inc 3Q 2023 - - - -
Bellicum Pharmaceuticals Inc 3Q 2023 down-0.89 % up 33300 % - -
Bellerophon Therapeutics inc 3Q 2023 - - - -
Biolinerx Ltd 4Q 2022 - - - -
Biomea Fusion Inc 3Q 2023 - - - -
Biomarin Pharmaceutical Inc 4Q 2023 up 20.22 % up 11.16 % - down -49.54 %
Bristol myers Squibb Company 4Q 2023 up 0.62 % up 4.66 % down -12.99 % down -8.89 %
Bionomics Limited 2Q 2023 down-91.64 % down -91.64 % - -
Benitec Biopharma Inc 4Q 2023 - - - -
Bolt Biotherapeutics Inc 3Q 2023 up 19.7 % up 76.41 % - -
Blueprint Medicines Corporation 4Q 2023 up 163.28 % up 37.5 % - -
Bio path Holdings Inc 3Q 2023 - - - -
Bespoke Extracts Inc 3Q 2023 - up 29.83 % - -
Bioxcel Therapeutics Inc 3Q 2023 up 148.91 % down -25.38 % - -
Blue Water Biotech Inc 3Q 2023 - - - -
Baudax Bio Inc 3Q 2023 - - - -
Beyondspring Inc 4Q 2022 flat 0 % flat 0 % - -
Calithera Biosciences Inc 4Q 2022 - - - -
Calcimedica Inc 3Q 2023 - - - -
Calliditas Therapeutics Ab 4Q 2022 - - - -
Can fite Biopharma Ltd 4Q 2022 down-5.04 % - - -
Capricor Therapeutics inc 3Q 2023 up 288.66 % up 57.9 % - -
Cara Therapeutics inc 3Q 2023 down-55 % down -29.81 % - -
Carisma Therapeutics Inc 3Q 2023 - up 7.5 % - -
Casi Pharmaceuticals inc 4Q 2022 up 370.7 % up 370.7 % - -
Cymabay Therapeutics Inc 4Q 2023 - - - -
Catalyst Biosciences Inc 3Q 2023 - - - -
Chemocentryx Inc. 2Q 2022 up 548.81 % up 115.48 % - -
Avid Bioservices Inc 3Q 2023 down-27.11 % down -31.71 % - -
Conduit Pharmaceuticals Inc 3Q 2023 - - up 859.86 % -
Celularity Inc 3Q 2023 down-8.44 % up 28.86 % - -
Chembio Diagnostics Inc 4Q 2022 down-49.72 % down -7.65 % - -
Cen Biotech Inc 3Q 2022 - - - -
Cerevel Therapeutics Holdings Inc 3Q 2023 - - - -
Contrafect Corporation 3Q 2023 - - - -
China Health Industries Holdings Inc 3Q 2023 up 11.07 % up 66.3 % - -
Cincor Pharma Inc 3Q 2022 - - - -
Cingulate Inc 3Q 2023 - - - -
Checkpoint Therapeutics inc 3Q 2023 down-35.42 % flat 0 % - -
Caladrius Biosciences Inc 1Q 2022 - - - -
Cell Source Inc 2Q 2023 - - - -
Clene Inc 3Q 2023 down-37.93 % down -59.85 % - -
Cellectar Biosciences inc 3Q 2023 - - - -
Clearside Biomedical Inc 3Q 2023 up 222.93 % down -15.62 % - -
Clever Leaves Holdings Inc 3Q 2023 down-10.98 % down -37.75 % - -
Clovis Oncology inc 3Q 2022 down-19.13 % down -4.6 % - -
Chemomab Therapeutics Ltd 1Q 2023 - - up 71.49 % up 5.81 %
Clearmind Medicine Inc 3Q 2023 - - - -
Compass Pathways Plc 4Q 2023 - - - -
Comera Life Sciences Holdings Inc 3Q 2023 down-41.98 % down -56.73 % - -
Chimerix Inc 4Q 2023 down-99.51 % down -63.64 % - -
Cnbx Pharmaceuticals Inc 4Q 2023 - down -10.56 % - -
Concert Pharmaceuticals Inc 3Q 2022 down-98.53 % down -61.9 % - -
Cns Pharmaceuticals Inc 3Q 2023 - up 65.12 % - -
Centessa Pharmaceuticals Plc 3Q 2023 - - - -
Connect Biopharma Holdings Limited 4Q 2022 - - - -
Context Therapeutics Inc 3Q 2023 - - - -
Cocrystal Pharma Inc 2Q 2023 - - - -
Cogent Biosciences Inc 3Q 2023 - - - -
Collegium Pharmaceutical Inc 4Q 2023 down-95.12 % down -96.87 % - up 54.79 %
Corcept Therapeutics Inc 4Q 2023 up 31.39 % up 9.55 % up 88.36 % down -0.04 %
Coya Therapeutics Inc 3Q 2023 - - - -
China Pharma Holdings Inc 3Q 2023 down-8.26 % up 64.27 % - -
Cumberland Pharmaceuticals Inc 3Q 2023 down-11.63 % down -7.37 % - -
Cannapharmarx Inc 3Q 2023 - - - -
Catalyst Pharmaceuticals Inc 4Q 2023 up 81.98 % up 7.67 % up 36.8 % -
Corbus Pharmaceuticals Holdings Inc 3Q 2023 - - - -
Cormedix Inc 3Q 2023 - - - -
Crinetics Pharmaceuticals Inc 3Q 2023 down-24.45 % down -64.98 % - -
Cervomed Inc 3Q 2023 - - - -
Corvus Pharmaceuticals Inc 3Q 2023 - - - -
Cti Biopharma Corp 1Q 2023 up 950.81 % up 14.39 % - -
Innovation Pharmaceuticals Inc 3Q 2023 - - - -
Catalent Inc 4Q 2023 down-10.88 % up 4.28 % - -
Cytomx Therapeutics Inc 3Q 2023 up 55.98 % up 6.71 % - -
Citius Pharmaceuticals Inc 4Q 2023 - - - -
Cue Biopharma Inc 3Q 2023 up 2988.24 % up 51.95 % - -
Cadrenal Therapeutics Inc 3Q 2023 - - - -
Cv Sciences Inc 3Q 2023 up 2.45 % up 3.36 % - -
Cohbar Inc 2Q 2023 - - - -
Celyad Oncology Sa 4Q 2022 - - - -
Cyclacel Pharmaceuticals Inc 3Q 2023 - down -95.71 % - -
Cyclerion Therapeutics Inc 1Q 2022 up 1046.77 % up 33.65 % - -
Cytodyn inc 4Q 2023 - - - -
Cryoport inc 3Q 2023 down-7.12 % down -1.52 % - -
Cyteir Therapeutics Inc 3Q 2023 - - - -
Cytokinetics Incorporated 3Q 2023 down-84.97 % down -56.4 % - -
Altamira Therapeutics Ltd 4Q 2022 - - - -
Dar Bioscience Inc 3Q 2023 - - - -
Day One Biopharmaceuticals Inc 3Q 2023 - - - -
Decibel Therapeutics Inc 2Q 2023 - - - -
Deciphera Pharmaceuticals Inc 4Q 2023 up 32.88 % up 11.5 % - -
Journey Medical Corporation 3Q 2023 up 114.31 % up 101.14 % - -
Dice Therapeutics Inc 2Q 2023 - - - -
Diamedica Therapeutics Inc 3Q 2023 - - - -
Dmk Pharmaceuticals Corporation 3Q 2023 down-99.4 % up 30.48 % - -
Dianthus Therapeutics Inc 3Q 2023 - - - -
Dermata Therapeutics Inc 3Q 2023 - - - -
Durect Corp 3Q 2023 down-85.44 % down -16.19 % - -
Bright Minds Biosciences Inc 3Q 2023 - - - -
Design Therapeutics Inc 3Q 2023 - - - -
Dynavax Technologies Corporation 3Q 2023 down-59.15 % up 13.72 % down -77.6 % up 316.58 %
Dyne Therapeutics Inc 3Q 2023 - - - -
Emergent Biosolutions Inc 4Q 2022 down-54.74 % up 36.38 % - -
Edesa Biotech Inc 4Q 2023 - - - -
Effector Therapeutics Inc 3Q 2023 - - - -
Eagle Pharmaceuticals inc 2Q 2023 down-12.8 % down -2.5 % - down -10.19 %
Elevai Labs Inc 3Q 2023 - - - -
Elanco Animal Health Inc 4Q 2023 up 5.5 % down -3.09 % - -
Eledon Pharmaceuticals Inc 3Q 2023 - - - -
Elite Pharmaceuticals Inc 1Q 2022 up 63.92 % down -19.72 % - up 6.36 %
Elicio Therapeutics Inc 3Q 2023 - - - -
Enliven Therapeutics Inc 3Q 2023 - - - -
Eliem Therapeutics Inc 3Q 2023 - - - -
Emmaus Life Sciences Inc 3Q 2023 up 1.6 % down -53.36 % - -
Endo International Plc 3Q 2023 down-16.62 % down -17.41 % - -
Enlivex Therapeutics Ltd 4Q 2022 - - - -
Ensysce Biosciences Inc 2Q 2023 up 136.41 % down -37.89 % - -
Enanta Pharmaceuticals Inc 3Q 2023 down-6.82 % up 0.21 % - -
Enveric Biosciences Inc 3Q 2023 - - - -
Evolus Inc 3Q 2023 up 47.55 % up 1.36 % - -
Essa Pharma inc 4Q 2023 - - - -
Epizyme Inc. 2Q 2022 up 111.59 % up 216.56 % - -
Equillium Inc 3Q 2023 - down -2.78 % - -
Eqrx Inc 3Q 2023 - - - -
Erasca Inc 3Q 2023 - - - -
Eterna Therapeutics Inc 3Q 2023 - - - -
Esperion Therapeutics inc 4Q 2023 up 71.38 % down -5.06 % - -
89bio Inc 3Q 2023 - - - -
Eton Pharmaceuticals Inc 3Q 2023 up 98.91 % down -45.19 % - -
Earth Science Tech Inc 4Q 2023 up 133208.25 % up 75.17 % - down -49.29 %
Entasis Therapeutics Holdings Inc 1Q 2022 - - - -
Evofem Biosciences Inc 3Q 2023 down-19.76 % up 107.97 % down -26.26 % -
Evelo Biosciences Inc 3Q 2023 - - - -
Evotec Se 4Q 2022 up 21.59 % up 21.59 % - -
Evoke Pharma Inc 3Q 2023 up 87.82 % up 38.14 % - -
Edgewise Therapeutics inc 4Q 2023 - - - -
Eyenovia inc 3Q 2023 - - - -
Fortress Biotech Inc 3Q 2023 up 110.26 % up 99.88 % - -
Forte Biosciences Inc 3Q 2023 - - - -
Fibrogen Inc 3Q 2023 up 155.06 % down -9.44 % - -
Foghorn Therapeutics Inc 3Q 2023 up 163.46 % up 212.16 % - -
Homology Medicines Inc 3Q 2023 - - - -
Flora Growth Corp 3Q 2023 - down -13.88 % - -
Amicus Therapeutics inc 4Q 2023 up 31.47 % up 12.93 % - -
Frequency Therapeutics Inc 3Q 2023 - - - -
F star Therapeutics Inc 3Q 2022 up 49.8 % - - -
Fulcrum Therapeutics Inc 3Q 2023 down-35.84 % down -13.75 % - -
First Wave Biopharma Inc 3Q 2023 - - - -
Galectin Therapeutics Inc 3Q 2023 - - - -
Gain Therapeutics inc 3Q 2023 - - - -
Generation Bio Co 3Q 2023 - up 143.86 % - -
Global Blood Therapeutics Inc. 2Q 2022 up 50.46 % up 29.71 % - -
The Greater Cannabis Company Inc 2Q 2023 - - - -
Geron Corp 3Q 2023 down-44.78 % up 465.52 % - -
Guardion Health Sciences Inc 3Q 2023 up 17.82 % up 9.38 % - -
Galmed Pharmaceuticals Ltd 4Q 2022 - - down -44.97 % down -44.97 %
Galapagos Nv 4Q 2022 up 4.21 % - - -
Gelesis Holdings Inc 2Q 2023 down-87.66 % down -36.85 % - -
Greenwich Lifesciences Inc 1Q 2022 - - - -
Galecto Inc 3Q 2023 - - - -
Glycomimetics Inc 3Q 2023 - - - -
Genelux Corporation 1Q 2023 - - - -
Genprex Inc 3Q 2023 - - - -
Gossamer Bio Inc 3Q 2023 - - - -
Geovax Labs Inc 3Q 2023 - - - -
Structure Therapeutics Inc 2Q 2023 - - - -
Gracell Biotechnologies Inc 4Q 2022 - - - -
Grifols Sa 4Q 2022 - - up 2.19 % up 2.19 %
Gri Bio Inc 3Q 2023 - - - -
Galera Therapeutics Inc 3Q 2023 - - - -
Globestar Therapeutics Corporation 3Q 2023 - - - -
Gt Biopharma Inc 3Q 2023 - - - -
G1 Therapeutics Inc 4Q 2023 up 45.1 % up 20.92 % - -
Hutchmed china Limited 4Q 2023 up 96.52 % up 96.52 % - -
Hcw Biologics Inc 3Q 2023 down-52.84 % up 36.98 % - -
Hepion Pharmaceuticals inc 3Q 2023 - - - -
Humanigen Inc 1Q 2023 down-78.67 % flat 0 % - -
Hookipa Pharma inc 3Q 2023 up 207.94 % up 156.33 % - -
Hoth Therapeutics Inc 3Q 2023 - up 262.47 % - -
Werewolf Therapeutics Inc 3Q 2023 up 18.65 % down -27.03 % - -
Inhibitor Therapeutics Inc 2Q 2023 - - - -
Harmony Biosciences Holdings inc 4Q 2023 up 31.3 % up 5.31 % down -45.15 % down -30.82 %
Harrow Inc 3Q 2023 up 49.84 % up 2.18 % - -
Heron Therapeutics Inc 3Q 2023 up 17.58 % down -1.69 % - -
Hst Global Inc 3Q 2023 - - - -
Histogen Inc 3Q 2023 flat 0 % flat 0 % - -
Fsd Pharma Inc 4Q 2022 - - - -
Horizon Therapeutics Public Limited Company 2Q 2023 up 7.71 % up 13.45 % up 108.4 % up 132.37 %
Ibio inc 3Q 2023 - - - -
Intercept Pharmaceuticals inc 3Q 2023 up 14.44 % up 6.06 % - -
Ideaya Biosciences Inc 3Q 2023 down-72.94 % up 126.81 % - -
Inflarx N v 4Q 2022 - - - -
Igc Pharma Inc 4Q 2023 down-38.55 % down -29.9 % - -
Igm Biosciences Inc 3Q 2023 - - - -
Intelgenx Technologies Corp 3Q 2023 down-20.1 % up 96.3 % - -
I mab 4Q 2022 - - - -
Immunogen inc 3Q 2023 up 637.72 % up 36.41 % - -
Imago Biosciences Inc 3Q 2022 - - - -
Immutep Limited 2Q 2023 down-23.05 % down -23.05 % - -
Immix Biopharma Inc 2Q 2022 - - - -
Immunome Inc 3Q 2023 - up 50.8 % - -
Imunon Inc 3Q 2023 - - - -
Impel Pharmaceuticals Inc 3Q 2023 up 55.52 % down -24.69 % - -
Immuron Limited 2Q 2023 - - - -
Immuneering Corporation 3Q 2023 - - - -
Biostax Corp 3Q 2023 - - - -
Immunic Inc 4Q 2023 - - - -
Integrated Biopharma Inc 4Q 2023 down-14.15 % down -18.02 % - -
Intercure Ltd 4Q 2022 up 76.93 % up 76.93 % up 499.88 % up 499.88 %
Indaptus Therapeutics Inc 2Q 2023 - - - -
Infinity Pharmaceuticals Inc 2Q 2023 down-15.01 % down -20.25 % - -
Inmed Pharmaceuticals Inc 4Q 2023 up 300.6 % up 37.52 % - -
Insmed Inc 4Q 2023 up 48.27 % up 10.15 % - -
Inozyme Pharma Inc 3Q 2023 - - - -
Io Biotech Inc 3Q 2023 - - - -
Ionis Pharmaceuticals Inc 4Q 2023 up 183.37 % up 162.9 % - -
Immunoprecise Antibodies Ltd 1Q 2023 - - - -
Intellipharmaceutics International Inc 4Q 2022 - - - -
Disc Medicine Inc 3Q 2023 - - - -
Ironwood Pharmaceuticals inc 4Q 2023 up 9.66 % up 3.35 % - -
International Stem Cell Corporation 3Q 2023 up 15.85 % up 7.17 % - -
Iveric Bio Inc 1Q 2023 - - - -
Intra cellular Therapies Inc 4Q 2023 up 50.34 % up 4.7 % - -
Iterum Therapeutics Plc 3Q 2023 - - - -
Inventiva S a 4Q 2022 - - - -
Incannex Healthcare Inc 4Q 2023 - - - -
Jaguar Health inc 3Q 2023 down-10.7 % up 5.12 % - -
Janone Inc 3Q 2023 - - - -
Janux Therapeutics Inc 3Q 2023 up 38.83 % up 138.13 % - -
Jazz Pharmaceuticals Plc 4Q 2023 down-18.92 % up 4.09 % - down -35.87 %
Johnson and Johnson 4Q 2023 down-42.92 % down -36.62 % up 15.03 % down -84.44 %
Kineta Inc 3Q 2023 - - - -
Kala Bio inc 3Q 2023 - - - -
Kalvista Pharmaceuticals Inc 3Q 2023 - - - -
Chinook Therapeutics Inc 2Q 2023 up 141.15 % down -44.86 % - -
Kiniksa Pharmaceuticals ltd 4Q 2023 up 34.76 % up 24.38 % up 465.73 % -
Kinnate Biopharma Inc 3Q 2023 - - - -
Kiora Pharmaceuticals Inc 3Q 2023 - - - -
Karyopharm Therapeutics Inc 3Q 2023 down-0.38 % down -4.18 % - -
Kronos Bio Inc 3Q 2023 - down -50.8 % - -
Keros Therapeutics Inc 4Q 2023 - up 186125 % - -
Karuna Therapeutics Inc 3Q 2023 - - - -
Kintara Therapeutics Inc 3Q 2023 - - - -
Pasithea Therapeutics Corp 3Q 2023 - - - -
Kura Oncology Inc 3Q 2023 - - - -
Kazia Therapeutics Limited 2Q 2023 down-96 % down -96 % - -
Kezar Life Sciences Inc 3Q 2023 - - - -
Longboard Pharmaceuticals Inc 3Q 2023 - - - -
Lannett Company Inc 1Q 2023 up 1.41 % up 9.29 % - -
Lexaria Bioscience Corp 4Q 2023 up 49.08 % - - -
Lifevantage Corp 4Q 2023 down-3.92 % up 0.73 % - -
Ligand Pharmaceuticals Incorporated 3Q 2023 down-50.27 % up 24.66 % - -
Longeveron Inc 3Q 2023 down-43.4 % down -30.88 % - -
Lianbio 3Q 2023 - - - -
Lftd Partners Inc 3Q 2023 up 16.63 % up 4.66 % up 45.85 % down -62.78 %
Lipella Pharmaceuticals Inc 4Q 2023 - up 16.14 % - -
Lixte Biotechnology Holdings Inc 3Q 2023 - - - -
Eli Lilly And Company 4Q 2023 up 28.1 % down -1.53 % up 13.01 % -
Landec Corporation 1Q 2022 down-61.61 % down -59.15 % - -
Lipocine Inc 3Q 2023 - - - -
Leap Therapeutics inc 3Q 2023 - - - -
Liquidia Corporation 3Q 2023 up 16.21 % down -23.15 % - -
Larimar Therapeutics Inc 3Q 2023 - - - -
Lucy Scientific Discovery Inc 4Q 2023 - - - -
Lantern Pharma Inc 2Q 2023 - - - -
Lumos Pharma Inc 3Q 2023 down-98.59 % down -98.67 % - -
Lexicon Pharmaceuticals Inc 3Q 2023 - down -48.9 % - -
Lyell Immunopharma Inc 4Q 2023 down-99.97 % down -48 % - -
Merrimack Pharmaceuticals Inc 3Q 2023 - - - -
Maia Biotechnology Inc 3Q 2023 - - - -
Mustang Bio inc 3Q 2023 - - - -
Moleculin Biotech Inc 3Q 2023 - - - -
Seres Therapeutics Inc 3Q 2023 down-91 % down -99.75 % - -
Madrigal Pharmaceuticals Inc 4Q 2023 - - - -
Medicenna Therapeutics Corp. 1Q 2022 - - - -
23andme Holding Co 4Q 2023 down-34.37 % down -11.65 % - -
Mei Pharma Inc 3Q 2023 up 647.96 % up 4381.61 % - -
Macrogenics Inc 3Q 2023 down-75.09 % down -20.85 % - down -69.45 %
Mira Pharmaceuticals Inc 2Q 2023 - - - -
Mirum Pharmaceuticals Inc 3Q 2023 up 154.13 % up 27.28 % - -
Milestone Pharmaceuticals Inc 3Q 2023 - - - -
Moonlake Immunotherapeutics 4Q 2023 - - - -
Mineralys Therapeutics Inc 3Q 2023 - - - -
Mallinckrodt Plc 3Q 2023 up 6.95 % up 4.61 % - -
Mannkind Corporation 3Q 2023 up 56.14 % up 5.43 % - -
Medicinova Inc 3Q 2023 - - - -
Monopar Therapeutics Inc 3Q 2023 - - - -
Morphic Holding inc 4Q 2023 - - - -
Medicure Inc 4Q 2022 up 6.08 % up 6.08 % - -
Mereo Biopharma Group Plc 4Q 2022 - - - -
Merck and Co Inc 3Q 2023 up 6.7 % up 6.17 % up 46.02 % -
Marker Therapeutics inc 3Q 2023 down-93.48 % down -66.22 % - -
Marinus Pharmaceuticals Inc 3Q 2023 up 213.59 % up 20.67 % - -
Mersana Therapeutics Inc 4Q 2023 down-27.14 % up 39.01 % - -
Mirati Therapeutics Inc 3Q 2023 up 201.97 % up 19.8 % - -
Merus N v 3Q 2023 up 67.65 % up 5.32 % - -
Maravai Lifesciences Holdings Inc 3Q 2023 down-65.04 % down -2.97 % - -
Musclepharm Corporation 1Q 2022 down-0.15 % up 30.46 % - -
Metacrine Inc 3Q 2022 - - - -
Molecular Templates inc 3Q 2023 down-19.92 % up 160.28 % down -80.78 % down -81.16 %
Matinas Biopharma Holdings Inc 2Q 2023 - - - -
Mural Oncology Plc 3Q 2023 - - - -
Mainz Biomed N v 4Q 2022 down-8.22 % down -8.22 % - -
Myovant Sciences Ltd 4Q 2022 up 84.11 % down -4.38 % - -
Innovation1 Biotech Inc 3Q 2023 - - - -
Nature s Sunshine Products inc 3Q 2023 up 5.48 % down -4.66 % up 1471 % up 17.37 %
Nascent Biotech Inc 4Q 2023 - - - -
Nabriva Therapeutics Plc 2Q 2023 down-75.6 % down -70.45 % - -
Neubase Therapeutics inc 3Q 2023 - - - -
Nanobiotix S a 4Q 2022 up 80.43 % up 80.43 % - -
Novabay Pharmaceuticals Inc 3Q 2023 up 11.29 % down -34.09 % - -
Nucana Plc 4Q 2022 - - - -
Neptune Wellness Solutions Inc 4Q 2023 down-37.75 % down -13.05 % - -
Minerva Neurosciences Inc 3Q 2023 - - - -
Neximmune Inc 3Q 2023 - - - -
Ngm Biopharmaceuticals Inc 3Q 2023 down-92.64 % down -59.1 % - -
Nighthawk Biosciences inc 3Q 2023 down-88.03 % up 9.93 % - -
Nektar Therapeutics 3Q 2023 up 2.2 % up 17.78 % - -
Nkarta Inc 3Q 2023 - - - -
Nls Pharmaceutics Ltd 4Q 2022 - - - -
Neoleukin Therapeutics Inc 3Q 2023 - - - -
9 Meters Biopharma Inc 1Q 2023 - - - -
Nanomix Corp 4Q 2022 - - - -
Nanoviricides inc 4Q 2023 - - - -
Novan Inc 1Q 2023 up 64.21 % down -69.79 % - -
Neurobo Pharmaceuticals Inc 3Q 2023 - - - -
Nurix Therapeutics Inc 4Q 2023 up 123.49 % down -17.91 % - -
Nrx Pharmaceuticals Inc 3Q 2023 - - - -
Rebus Holdings Inc 2Q 2023 - - - -
Nuvation Bio Inc 3Q 2023 - - - -
Nuvalent Inc 3Q 2023 - - - -
Nuvectis Pharma inc 1Q 2023 - - - -
Novartis Ag 4Q 2023 down-9.97 % down -9.97 % up 113.57 % up 113.57 %
Northwest Biotherapeutics inc 3Q 2023 up 97.09 % up 101.99 % - -
Nexien Biopharma Inc 2Q 2022 - - - -
Nextcure Inc 3Q 2023 - - - -
Theralink Technologies Inc 4Q 2023 down-72.5 % down -58.53 % - -
Obseva Sa 4Q 2022 - up 38.45 % - -
Oculis Holding Ag 4Q 2022 - - - -
Ocular Therapeutix Inc 3Q 2023 up 26.04 % down -0.69 % - -
Ocuphire Pharma Inc 3Q 2023 - up 224.85 % - -
Oragenics Inc 2Q 2023 down-56.69 % down -22.68 % - -
Organigram Holdings Inc 3Q 2023 - - - -
Organon and Co 4Q 2023 up 7.61 % up 5.2 % up 405.56 % up 841.38 %
Olema Pharmaceuticals inc 3Q 2023 - - - -
Omeros Corp 3Q 2023 - - - -
Oncorus Inc 1Q 2023 - - - -
Oncosec Medical Incorporated 4Q 2022 - - - -
Oncternal Therapeutics Inc 3Q 2023 down-53.14 % up 68.87 % - -
Oncolytics Biotech Inc 4Q 2022 - - - -
Onconova Therapeutics inc 3Q 2023 flat 0 % flat 0 % - -
Opko Health Inc 3Q 2023 down-0.64 % down -32.71 % - -
Opiant Pharmaceuticals Inc 3Q 2022 down-98.94 % down -95.54 % - -
Optinose Inc 3Q 2023 down-1.27 % up 1.9 % - -
Organogenesis Holdings Inc 3Q 2023 down-7.13 % down -7.49 % up 1373.02 % down -40.43 %
Orgenesis Inc 2Q 2023 down-3.14 % down -0.98 % down -33.34 % down -14.08 %
Oric Pharmaceuticals Inc 3Q 2023 - - - -
Oramed Pharmaceuticals Inc 3Q 2023 - - down -70.33 % up 150.11 %
Otonomy Inc 3Q 2022 - - - -
Oncotelic Therapeutics Inc 3Q 2023 - - - -
Ovid Therapeutics Inc 3Q 2023 up 881.55 % up 45.3 % - -
One World Products Inc 3Q 2022 - up 228.9 % - -
Phibro Animal Health Corporation 4Q 2023 up 2.03 % up 8.19 % down -82.33 % -
Prestige Consumer Healthcare Inc 4Q 2023 up 2.33 % down -1.43 % up 2.13 % down -1.09 %
Panbela Therapeutics Inc 3Q 2023 - - - -
Puma Biotechnology Inc 3Q 2023 down-1.73 % up 2.84 % - up 172.62 %
Rapid Therapeutic Science Laboratories Inc 2Q 2023 - - - down -75.73 %
Pacira Biosciences inc 3Q 2023 down-2.11 % down -3.27 % - down -57.85 %
Processa Pharmaceuticals Inc 2Q 2023 - - - -
Procyon Corporation 4Q 2023 up 1.36 % up 2.3 % - -
Pds Biotechnology Corp 3Q 2023 - - - -
Pepgen Inc 3Q 2023 - - - -
Pfizer Inc 4Q 2023 down-41.34 % up 7.68 % - -
Precigen Inc 3Q 2023 down-91.75 % down -21.96 % - -
Pharming Group N v 4Q 2022 up 3.39 % - down -14.52 % -
Phasebio Pharmaceuticals Inc. 2Q 2022 down-97.99 % up 77.78 % - -
Phathom Pharmaceuticals Inc 3Q 2023 - - - -
Phio Pharmaceuticals Corp 3Q 2023 - - - -
Pharvaris N v 4Q 2022 - - - -
Pieris Pharmaceuticals Inc 3Q 2023 up 263.5 % down -2.67 % - -
Peak Pharmaceuticals Inc 4Q 2022 - - - -
Protokinetix Incorporated 3Q 2023 - - - -
Pliant Therapeutics Inc 3Q 2023 - - - -
Plx Pharma Inc 3Q 2022 down-94.17 % down -20.08 % - -
Promis Neurosciences inc 3Q 2023 - - - -
Pmv Pharmaceuticals Inc 3Q 2023 - - - -
Point Biopharma Global Inc 3Q 2023 - down -42.66 % - -
Purple Biotech Ltd 4Q 2022 - - up 17.83 % up 17.83 %
Propanc Biopharma Inc 2Q 2022 - - - -
Praxis Precision Medicines Inc 3Q 2023 - down -40.08 % - -
Pardes Biosciences Inc 2Q 2023 - - - -
Perrigo Company Plc 4Q 2023 up 0.16 % up 3.13 % - -
Prelude Therapeutics Inc 3Q 2023 - - - -
Procaps Group S a 4Q 2022 - - - -
Prophase Labs Inc 3Q 2023 down-65.59 % down -33.11 % - -
Proqr Therapeutics N v 4Q 2022 - - - -
Prothena Corporation Public Limited Company 4Q 2023 down-99.37 % down -99.63 % - -
Puretech Health Plc 4Q 2022 up 32.72 % up 32.72 % - -
Portage Biotech Inc. 1Q 2022 - - - -
Paratek Pharmaceuticals Inc 1Q 2023 up 25.64 % down -58.66 % - -
Provention Bio Inc 4Q 2022 up 1408.09 % up 1330.29 % - -
Ptc Therapeutics inc 3Q 2023 down-9.46 % down -8.06 % - -
Protagonist Therapeutics inc 4Q 2023 - - - -
Protagenic Therapeutics Inc new 2Q 2022 - - - -
Palatin Technologies Inc 4Q 2023 up 98.18 % down -3.41 % - -
Petros Pharmaceuticals inc 3Q 2023 - down -33.49 % - -
Pulmatrix Inc 2Q 2022 down-40.95 % up 14.74 % - -
Provectus Biopharmaceuticals Inc 3Q 2023 down-77.85 % down -56.91 % - -
Paxmedica inc 3Q 2023 - - - -
Pyxis Oncology Inc 3Q 2023 - - - -
Q Biomed inc 1Q 2023 - - - -
Qualigen Therapeutics Inc 3Q 2023 - - - -
Qilian International Holding Group Limited 3Q 2023 down-29.46 % down -29.46 % - -
Uniqure N v 3Q 2023 down-2.9 % down -41.91 % - -
Rain Oncology Inc 3Q 2023 - - - -
Rani Therapeutics Holdings Inc 3Q 2023 - - - -
Rapt Therapeutics Inc 3Q 2023 - - - -
Ultragenyx Pharmaceutical Inc 3Q 2023 up 8.1 % down -9.47 % - -
Actavia Life Sciences Inc 4Q 2023 down-52.22 % up 282.24 % - -
Rocket Pharmaceuticals Inc 3Q 2023 - - - -
Arcus Biosciences Inc 4Q 2023 down-7.89 % down -3.13 % - -
Redhill Biopharma Ltd 4Q 2022 down-27.94 % down -27.94 % down -26.68 % down -26.68 %
Dr Reddy s Laboratories Limited 1Q 2023 up 5.87 % up 5.87 % up 76.21 % up 76.21 %
Regeneron Pharmaceuticals Inc 4Q 2023 up 0.58 % up 2.13 % down -3.13 % up 15.06 %
Renovaro Inc 4Q 2023 - - - -
Reata Pharmaceuticals Inc 2Q 2023 up 2885.04 % up 11564.62 % - -
Revelation Biosciences Inc 3Q 2023 - - - -
Regen Biopharma Inc 4Q 2023 flat 0 % flat 0 % - -
Regulus Therapeutics Inc 3Q 2023 - - - -
Regenerx Biopharmaceuticals inc 1Q 2023 down-0.01 % up 0.01 % - -
Rigel Pharmaceuticals Inc 3Q 2023 up 25.54 % up 4.64 % - -
Relmada Therapeutics Inc 3Q 2023 - - - -
Rallybio Corporation 3Q 2023 - - - -
Rockwell Medical inc 3Q 2023 up 30.52 % up 28.66 % - -
Avidity Biosciences Inc 4Q 2023 down-20.8 % down -22.18 % - -
Transcode Therapeutics Inc 3Q 2023 - - - -
Renovorx Inc 3Q 2023 - - - -
Roivant Sciences Ltd 4Q 2023 up 117.8 % up 0.11 % - -
Reneo Pharmaceuticals Inc 3Q 2023 - - - -
Royalty Pharma Plc 4Q 2023 up 5.36 % up 11.14 % - up 487.81 %
Repare Therapeutics Inc 3Q 2023 down-98.08 % down -92.86 % - -
Respirerx Pharmaceuticals Inc 2Q 2023 - - - -
Rvl Pharmaceuticals Plc 2Q 2023 down-13.45 % down -17.21 % - -
Revance Therapeutics Inc 4Q 2023 up 39.82 % up 22.94 % up 1.06 % -
Reviva Pharmaceuticals Holdings Inc 3Q 2023 - - - -
Prometheus Biosciences Inc 1Q 2023 down-71.8 % up 69.22 % - -
Rhythm Pharmaceuticals inc 3Q 2023 up 425.3 % up 17.08 % - -
Rayzebio Inc 3Q 2023 - - - -
Rezolute Inc 4Q 2023 - - - -
Sage Therapeutics Inc 3Q 2023 up 56.18 % up 9.78 % - -
Cassava Sciences Inc 4Q 2023 - - - -
Sunshine Biopharma Inc 3Q 2023 up 4385.93 % up 7.14 % - -
Scpharmaceuticals Inc 3Q 2023 - up 131.75 % - -
Scopus Biopharma Inc 2Q 2023 - - - -
Societal Cdmo Inc 3Q 2023 up 9.27 % up 8.22 % - -
Scynexis Inc 3Q 2023 up 13.1 % down -98.66 % - -
Schrodinger Inc 4Q 2023 up 30.33 % up 77.91 % - -
Seelos Therapeutics inc 3Q 2023 up 1127.78 % up 5.49 % - -
Cartesian Therapeutics Inc 3Q 2023 down-68.37 % up 24.8 % - -
Sangui Biotech International Inc 1Q 2023 up 4.14 % up 75.94 % - -
Sagimet Biosciences inc 3Q 2023 - - - -
Sigilon Therapeutics Inc 2Q 2023 up 104.65 % up 21.45 % - -
Shuttle Pharmaceuticals Holdings Inc 4Q 2022 - - - -
Siga Technologies Inc 3Q 2023 down-87.21 % up 57.11 % - -
Sio Gene Therapies Inc 4Q 2022 - - - -
Skinvisible Inc 3Q 2023 down-91.66 % flat 0 % - -
Skye Bioscience Inc 3Q 2023 - - - -
Acelyrin Inc 3Q 2023 - - - -
Salarius Pharmaceuticals inc 3Q 2023 - - - -
Sellas Life Sciences Group Inc 3Q 2023 - - - -
Summit Therapeutics Inc 4Q 2023 - - - -
Syndax Pharmaceuticals Inc 3Q 2023 - - - -
Soligenix inc 3Q 2023 down-21.49 % down -36.96 % - -
Sonoma Pharmaceuticals Inc 4Q 2023 up 6.59 % up 14.9 % - -
Synaptogenix Inc 3Q 2023 - - down -50.9 % down -86.03 %
Sensei Biotherapeutics Inc 3Q 2023 - - - -
Sanofi 4Q 2023 up 2.32 % up 2.32 % down -35.93 % down -35.93 %
Sonnet Biotherapeutics Holdings Inc 4Q 2023 down-50 % down -74.73 % - -
Spectrum Pharmaceuticals Inc 1Q 2023 - up 54.39 % - -
Spruce Biosciences Inc 3Q 2023 - up 41.94 % - -
Scisparc Ltd 4Q 2022 - - down -55.23 % down -55.23 %
Spero Therapeutics Inc 3Q 2023 up 1169.84 % up 837.89 % - -
Ars Pharmaceuticals Inc 3Q 2023 - - - -
Sarepta Therapeutics Inc 3Q 2023 up 44.1 % up 27.02 % - -
Sierra Oncology Inc 1Q 2022 - - - -
Statera Biopharma Inc fka Cytocom Inc 3Q 2022 up 183.48 % down -12.79 % - -
Stoke Therapeutics Inc 3Q 2023 up 13.87 % - - -
Satsuma Pharmaceuticals Inc 1Q 2023 - - - -
Shattuck Labs Inc 3Q 2023 up 223.58 % up 243 % - -
Supernus Pharmaceuticals inc 3Q 2023 down-13.24 % up 13.51 % - -
Sunwin Stevia International Inc. 2Q 2022 up 23 % down -2.24 % - -
Sinovac Biotech Ltd 4Q 2022 down-92.3 % down -92.3 % down -99.39 % down -99.39 %
Savara Inc 3Q 2023 - - - -
60 Degrees Pharmaceuticals Inc 2Q 2023 - - - -
Synlogic Inc 3Q 2023 down-42.04 % up 1022.86 % - -
Syros Pharmaceuticals Inc 3Q 2023 down-3.32 % up 32.79 % - -
Takeda Pharmaceutical Company Limited 1Q 2023 - - up 30.34 % up 30.34 %
Taro Pharmaceutical Industries Ltd 1Q 2023 up 2.07 % up 2.07 % down -56.33 % down -56.33 %
Theravance Biopharma inc 3Q 2023 up 26.04 % up 14.14 % - -
Tricida Inc 3Q 2022 - - - -
Alaunos Therapeutics Inc 3Q 2023 - - - -
Tenx Keane Acquisition 4Q 2022 - - - -
Tenax Therapeutics Inc 3Q 2023 - - down -32.39 % up 78.24 %
Terns Pharmaceuticals Inc 3Q 2023 - - - -
Teva Pharmaceutical Industries Limited 4Q 2023 up 14.76 % up 15.74 % - up 392.05 %
Tff Pharmaceuticals Inc 3Q 2023 up 738.32 % down -29.57 % - -
Tg Therapeutics Inc 3Q 2023 up 176298.94 % up 931.57 % - -
Tharimmune Inc 4Q 2023 - - - -
Third Harmonic Bio Inc 3Q 2023 - - down -10.51 % down -2.87 %
Thorne Healthtech Inc 2Q 2023 up 29.69 % up 11.46 % - -
Theseus Pharmaceuticals Inc 3Q 2023 - - - -
Theratechnologies Inc 4Q 2023 - - - -
Tiziana Life Sciences Ltd 4Q 2022 - - - -
Timber Pharmaceuticals Inc 2Q 2023 - - - -
Tango Therapeutics Inc 3Q 2023 up 55.09 % down -26.48 % - -
Tonix Pharmaceuticals Holding Corp 3Q 2023 - - - -
Theriva Biologics inc 3Q 2023 - - - -
Tempest Therapeutics Inc 3Q 2023 - - - -
Turning Point Therapeutics Inc. 2Q 2022 down-97.7 % down -72.26 % - -
Entrada Therapeutics Inc 3Q 2023 - up 140.7 % - -
Trevi Therapeutics Inc 3Q 2023 - - - -
Trevena inc 3Q 2023 - - - -
2seventy Bio Inc 3Q 2023 down-10.25 % down -66.62 % - -
Travere Therapeutics Inc 4Q 2023 - - - -
Therapeuticsmd Inc 3Q 2023 - - - -
Neuropathix Inc. 1Q 2022 up 549.94 % up 78.56 % - -
Tyme Technologies Inc. 2Q 2022 - - - -
Tyra Biosciences Inc 3Q 2023 - - - -
Unity Biotechnology Inc 3Q 2023 - - - -
Unicycive Therapeutics Inc 3Q 2023 - - - -
Universe Pharmaceuticals Inc 3Q 2023 down-19.52 % down -19.52 % - -
Urogen Pharma Ltd 3Q 2023 up 27.26 % down -1.02 % - -
United Therapeutics Corporation 4Q 2023 up 25.07 % up 0.87 % up 64.35 % down -18.87 %
Vaccitech Plc 2Q 2023 down-98.04 % down -28.63 % - -
Avricore Health Inc 4Q 2022 up 1339.95 % up 1339.95 % - -
Vaxxinity Inc 3Q 2023 - - - -
Vbi Vaccines Inc 3Q 2023 up 1989.59 % up 820 % - -
Vascular Biogenics Ltd 4Q 2022 - down -14.32 % - up 7.97 %
Vaccinex Inc 3Q 2023 down-60 % - - -
Vera Therapeutics Inc 3Q 2023 - - - -
Veru Inc 3Q 2023 up 25.22 % up 0.34 % - -
Verve Therapeutics Inc 3Q 2023 up 235.52 % up 48.92 % - -
Viveon Health Acquisition Corp 4Q 2022 - - - -
Vincerx Pharma Inc 3Q 2023 - - - -
Virios Therapeutics inc 3Q 2023 - - - -
Viracta Therapeutics Inc 3Q 2023 - - - -
Viking Therapeutics Inc 3Q 2023 - - - -
Vanda Pharmaceuticals Inc 4Q 2023 down-29.79 % up 16.63 % - -
Verrica Pharmaceuticals Inc 3Q 2023 down-64.94 % up 1502.75 % - -
Verona Pharma Plc 4Q 2023 - - - -
Virpax Pharmaceuticals Inc 3Q 2023 - - - -
Vertex Pharmaceuticals Inc 4Q 2023 up 9.34 % up 1.38 % up 18.31 % down -6.42 %
Verastem Inc 3Q 2023 - - - -
Vistagen Therapeutics Inc 4Q 2023 - up 48.15 % - -
Viatris Inc 4Q 2023 down-1 % down -2.65 % - -
Vtv Therapeutics Inc 3Q 2023 - - - -
Ventyx Biosciences Inc 3Q 2023 - - - -
Vyne Therapeutics Inc 3Q 2023 down-31.74 % down -15.56 % - -
Wellness Center Usa Inc 2Q 2022 up 36.73 % up 7.51 % - -
Wave Life Sciences Ltd 3Q 2023 up 17168.07 % up 122.63 % - -
Xenetic Biosciences Inc 3Q 2023 up 47.54 % down -6.12 % - -
Xbiotech Inc 3Q 2023 - - - -
Exicure Inc 2Q 2023 - - - -
Xenon Pharmaceuticals Inc 3Q 2023 - - - -
Xeris Biopharma Holdings Inc 3Q 2023 up 62.56 % up 27.13 % down -0.29 % down -49.93 %
Xilio Therapeutics inc 3Q 2023 - - - -
Xencor Inc 4Q 2023 up 106.8 % down -24.47 % - -
Xoma Corporation 3Q 2023 up 84.04 % down -49.94 % - -
Novaccess Global Inc 4Q 2023 - - - -
Xtl Biopharmaceuticals Ltd 4Q 2022 - - - -
Y mabs Therapeutics inc 3Q 2023 up 63.15 % down -1.43 % - -
Ys Biopharma Co Ltd 1Q 2023 - - - -
Zai Lab Limited 4Q 2023 up 5.16 % down -4.91 % - -
Zentalis Pharmaceuticals Inc 4Q 2023 - - - -
Zomedica Corp 3Q 2023 up 12.27 % up 6.22 % - -
Zosano Pharma Corporation 1Q 2022 down-48.84 % up 51.72 % - -
Zoetis Inc 4Q 2023 up 8.48 % up 2.88 % up 13.7 % down -12.25 %
Zevra Therapeutics Inc 3Q 2023 up 0.73 % down -65.82 % - -
Zyversa Therapeutics Inc 2Q 2023 - - - -
Zymeworks Inc 3Q 2023 up 527.37 % up 135.73 % - -
Zynerba Pharmaceuticals Inc 2Q 2023 - - - -
Revenue
Major Pharmaceutical Preparations Industry

recorded in the 4. Quarter 2023 above average Revenue deterioration of -56648.85 % year on year, Total Ranking #45 and ranking within sector #4.

Sequentially Revenues for Major Pharmaceutical Preparations Industry fell by -61086.21 %.

More on Major Pharmaceutical Preparations Industry Revenue Growth




Income
Major Pharmaceutical Preparations Industry
in the 4. Quarter 2023 Net income contracted by -24.11 % year on year.

Sequentially, Major Pharmaceutical Preparations Industry Net income fell by -60.61 % sequentially.

More on Major Pharmaceutical Preparations Industry Income Growth










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com